The above results showed that YTHDC1 played an important role in regulating the progression and drug resistance of renal cancer cells, which suggests that YTHDC1 might be an ideal candidate for the treatment of ccRCC. Here, YTHDC1 is linked to nonpapillary renal cell carcinoma.